This ‘can’t be about COVID at this stage,’ he said. It’s about ‘some type of totalitarian takeover that’s occurred all over the world. Something very dark is going on.’
(LifeSiteNews) — Eminent COVID-19 expert and highly published physician Dr. Peter McCullough provided a comprehensive well-documented presentation to colleagues regarding the “unbelievable atrocity” occurring in the West due to gene-transfer vaccine campaigns, the necessity for an “unbreakable resistance” against children receiving the jab, and the “astounding … ineptitude and willful misconduct” of public health agencies.
McCullough, who has made the case that no one in the world has more authority on this topic than him, provided detailed analysis of multiple scientific studies and data reports demonstrating the “failure of the vaccine program,” the suppression of effective early treatments, and the “robust, complete and durable” qualities of natural immunity.
Dr. Robert Malone, the architect of the mRNA platform used by the Pfizer and Moderna vaccines, and organizing co-signer of a recent public declaration in defense of early treatments, promoted the presentation, tweeting, “I’ll say it again. Watch the speech from Dr. Peter McCullough. He is on fire. And he is spot on. He [sic] summary of the data are [sic] precise and detailed. Please take the time to watch that video. And get outraged.”
Among many topics addressed by McCullough at the October 2 annual meeting of the American Association of Physicians and Surgeons was an initial focus on the serious lack of transparency of safety data and proper monitoring of the program.
“I have chaired data safety monitoring boards for over two dozen therapeutic products,” McCullough told his audience. His participation in this capacity has included heading boards for the National Institutes of Health (NIH) and Big Pharma corporations.
Data Safety Monitoring Boards (DSMB) are defined as a “ committee of clinical research experts … who monitor the progress of a clinical trial and review safety and effectiveness data while the trial is ongoing. This committee is independent of the people, organizations, and institutions conducting the clinical trial … [and] can recommend that a trial be stopped early because of concerns about participant safety …”
“I have made some critical calls as a chairman of a data safety monitoring board to shut down a program when it wasn’t safe,” McCullough explained. “And, I can tell you, that threshold is a few cases where we can’t explain it, a fewcases. We get to five unexplained cases [and] we start to get very, very uncomfortable.” When “we get to 50 unexplained deaths in a release of a product, it’s gone. It’s gone. We shut it down and we figure out what went wrong. For new biologic products demand safety, safety, safety.”